Latest filing published 18 Dec 2025 for Organogenesis Holdings Inc., €874k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Glenn H. Nussdorf (board member) discloses dealings in Organogenesis Holdings Inc. to SEC (Form 4). Between 6 May 2021 and 16 December 2025, the trades on record add up to 6 filings.
The open-market side counts 2 purchases for €912k alongside 3 sales for €53.6M. Sales outweigh purchases by €52.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 1 purchase and 2 sales on the market.
On 18 December 2025 came the latest disclosure, an open-market sale for €874k in Organogenesis Holdings Inc. The last purchase on record was published on 3 November 2025, which is 349 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations